<?xml version="1.0" ?><!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st June 2018//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_180601.dtd"><PubmedArticleSet><PubmedArticle>    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">        <PMID Version="1">30400234</PMID>        <DateRevised>            <Year>2018</Year>            <Month>11</Month>            <Day>09</Day>        </DateRevised>        <Article PubModel="Electronic">            <Journal>                <ISSN IssnType="Print">2072-6694</ISSN>                <JournalIssue CitedMedium="Print">                    <Volume>10</Volume>                    <Issue>11</Issue>                    <PubDate>                        <Year>2018</Year>                        <Month>Nov</Month>                        <Day>02</Day>                    </PubDate>                </JournalIssue>                <Title>Cancers</Title>                <ISOAbbreviation>Cancers (Basel)</ISOAbbreviation>            </Journal>            <ArticleTitle>A Recurrent <i>BRCA2</i> Mutation Explains the Majority of Hereditary Breast and Ovarian Cancer Syndrome Cases in Puerto Rico.</ArticleTitle>            <ELocationID EIdType="pii" ValidYN="Y">E419</ELocationID>            <ELocationID EIdType="doi" ValidYN="Y">10.3390/cancers10110419</ELocationID>            <Abstract>                <AbstractText>Breast cancer is the most common cause of cancer diagnosis in women and is responsible for considerable mortality among the women of Puerto Rico. However, there are few studies in Puerto Rico on the genetic factors influencing risk. To determine the contribution of pathogenic mutations in <i>BRCA1</i> and <i>BRCA2</i>, we sequenced these genes in 302 cases from two separate medical centers, who were not selected for age of onset or family history. We identified nine cases that are carriers of pathogenic germline mutation. This represents 2.9% of unselected cases and 5.6% of women meeting National Comprehensive Cancer Network (NCCN) criteria for BRCA testing. All of the identified pathogenic mutations were in the <i>BRCA2</i> gene and the most common mutation is the p.Glu1308Ter (E1308X) mutation in <i>BRCA2</i> found in eight out of nine cases, representing 89% of the pathogenic carriers. The E1308X mutation has been identified in breast and ovarian cancer families in Spain, and analysis of flanking DNA polymorphisms shows that all E1308X carriers occur on the same haplotype. This is consistent with <i>BRCA2</i> E1308X being a founder mutation for the Puerto Rican population. These results will contribute to better inform genetic screening and counseling of breast and ovarian cancer cases in Puerto Rico and Puerto Rican populations in mainland United States.</AbstractText>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Diaz-Zabala</LastName>                    <ForeName>Hector J</ForeName>                    <Initials>HJ</Initials>                    <AffiliationInfo>                        <Affiliation>Cancer Biology Division, Ponce Research Institute, Ponce Health Sciences University, Ponce, Ponce, PR 00716-2348, USA. diazhectorjoel@gmail.com.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Ortiz</LastName>                    <ForeName>Ana P</ForeName>                    <Initials>AP</Initials>                    <AffiliationInfo>                        <Affiliation>Cancer Control and Population Sciences Program, Comprehensive Cancer Center, University of Puerto Rico, San Juan, PR 00936-5067, USA. ana.ortiz7@upr.edu.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Garland</LastName>                    <ForeName>Lisa</ForeName>                    <Initials>L</Initials>                    <AffiliationInfo>                        <Affiliation>Cancer Genomics Research Laboratory, Leidos Biomedical Research, Inc., Frederick, MD 21702, USA. garlandlr@mail.nih.gov.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Jones</LastName>                    <ForeName>Kristine</ForeName>                    <Initials>K</Initials>                    <AffiliationInfo>                        <Affiliation>Cancer Genomics Research Laboratory, Leidos Biomedical Research, Inc., Frederick, MD 21702, USA. kristine.jones@nih.gov.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Perez</LastName>                    <ForeName>Cynthia M</ForeName>                    <Initials>CM</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Biostatistics and Epidemiology, Graduate School of Public Health, University of Puerto Rico, San Juan, PR 00936-5067, USA. cynthia.perez1@upr.edu.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Mora</LastName>                    <ForeName>Edna</ForeName>                    <Initials>E</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Surgery, School of Medicine, University of Puerto Rico and University of Puerto Rico Comprehensive Cancer Center, San Juan, PR 00936-5067, USA. emora@cccupr.org.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Arroyo</LastName>                    <ForeName>Nelly</ForeName>                    <Initials>N</Initials>                    <AffiliationInfo>                        <Affiliation>Cancer Biology Division, Ponce Research Institute, Ponce Health Sciences University, Ponce, Ponce, PR 00716-2348, USA. narroyo@psm.edu.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Oleksyk</LastName>                    <ForeName>Taras K</ForeName>                    <Initials>TK</Initials>                    <AffiliationInfo>                        <Affiliation>Biology Department, Oakland University, Rochester, MI 48309-4454, USA. oleksyk@oakland.edu.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Department of Biology, University of Puerto Rico in Mayaguez, Mayaguez, PR 00681, USA. oleksyk@oakland.edu.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Echenique</LastName>                    <ForeName>Miguel</ForeName>                    <Initials>M</Initials>                    <AffiliationInfo>                        <Affiliation>Cancer Center, Auxilio Mutuo Hospital, San Juan, PR 00936-5067, USA. echeniquemm@gmail.com.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Matta</LastName>                    <ForeName>Jaime L</ForeName>                    <Initials>JL</Initials>                    <Identifier Source="ORCID">0000-0001-6668-9021</Identifier>                    <AffiliationInfo>                        <Affiliation>Cancer Biology Division, Ponce Research Institute, Ponce Health Sciences University, Ponce, Ponce, PR 00716-2348, USA. jmatta@psm.edu.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Dean</LastName>                    <ForeName>Michael</ForeName>                    <Initials>M</Initials>                    <Identifier Source="ORCID">0000-0003-2234-0631</Identifier>                    <AffiliationInfo>                        <Affiliation>Laboratory of Translational Genomics, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Gaithersburg, MD 20877, USA. deanm@mail.nih.gov.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Dutil</LastName>                    <ForeName>Julie</ForeName>                    <Initials>J</Initials>                    <AffiliationInfo>                        <Affiliation>Cancer Biology Division, Ponce Research Institute, Ponce Health Sciences University, Ponce, Ponce, PR 00716-2348, USA. jdutil@psm.edu.</Affiliation>                    </AffiliationInfo>                </Author>            </AuthorList>            <Language>eng</Language>            <GrantList CompleteYN="Y">                <Grant>                    <GrantID>R25 GM082406</GrantID>                    <Acronym>GM</Acronym>                    <Agency>NIGMS NIH HHS</Agency>                    <Country>United States</Country>                </Grant>                <Grant>                    <GrantID>R25GM082406</GrantID>                    <Agency>National Institute of General Medical Sciences</Agency>                    <Country/>                </Grant>                <Grant>                    <GrantID>CA096300</GrantID>                    <Agency>National Cancer Institute</Agency>                    <Country/>                </Grant>                <Grant>                    <GrantID>SC1 CA182846</GrantID>                    <Acronym>CA</Acronym>                    <Agency>NCI NIH HHS</Agency>                    <Country>United States</Country>                </Grant>                <Grant>                    <GrantID>9SC1CA182846</GrantID>                    <Agency>National Cancer Institute</Agency>                    <Country/>                </Grant>                <Grant>                    <GrantID>S06 GM008239</GrantID>                    <Acronym>GM</Acronym>                    <Agency>NIGMS NIH HHS</Agency>                    <Country>United States</Country>                </Grant>                <Grant>                    <GrantID>1SC1CA182845</GrantID>                    <Agency>National Cancer Institute</Agency>                    <Country/>                </Grant>                <Grant>                    <GrantID>CA163071</GrantID>                    <Agency>National Cancer Institute</Agency>                    <Country/>                </Grant>                <Grant>                    <GrantID>G12 MD007579</GrantID>                    <Acronym>MD</Acronym>                    <Agency>NIMHD NIH HHS</Agency>                    <Country>United States</Country>                </Grant>                <Grant>                    <GrantID>MD007579</GrantID>                    <Agency>National Institute on Minority Health and Health Disparities</Agency>                    <Country/>                </Grant>                <Grant>                    <GrantID>U54 CA163071</GrantID>                    <Acronym>CA</Acronym>                    <Agency>NCI NIH HHS</Agency>                    <Country>United States</Country>                </Grant>                <Grant>                    <GrantID>S06-GM008239</GrantID>                    <Agency>National Institute of General Medical Sciences</Agency>                    <Country/>                </Grant>                <Grant>                    <GrantID>CA096297</GrantID>                    <Agency>National Cancer Institute</Agency>                    <Country/>                </Grant>                <Grant>                    <GrantID>SC1 CA182845</GrantID>                    <Acronym>CA</Acronym>                    <Agency>NCI NIH HHS</Agency>                    <Country>United States</Country>                </Grant>            </GrantList>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>            </PublicationTypeList>            <ArticleDate DateType="Electronic">                <Year>2018</Year>                <Month>11</Month>                <Day>02</Day>            </ArticleDate>        </Article>        <MedlineJournalInfo>            <Country>Switzerland</Country>            <MedlineTA>Cancers (Basel)</MedlineTA>            <NlmUniqueID>101526829</NlmUniqueID>            <ISSNLinking>2072-6694</ISSNLinking>        </MedlineJournalInfo>        <KeywordList Owner="NOTNLM">            <Keyword MajorTopicYN="N">BRCA1/BRCA2</Keyword>            <Keyword MajorTopicYN="N">Hispanic and Latino populations</Keyword>            <Keyword MajorTopicYN="N">breast cancer genetics</Keyword>            <Keyword MajorTopicYN="N">founder effect</Keyword>        </KeywordList>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="received">                <Year>2018</Year>                <Month>08</Month>                <Day>14</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="revised">                <Year>2018</Year>                <Month>10</Month>                <Day>22</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="accepted">                <Year>2018</Year>                <Month>10</Month>                <Day>26</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="entrez">                <Year>2018</Year>                <Month>11</Month>                <Day>8</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="pubmed">                <Year>2018</Year>                <Month>11</Month>                <Day>8</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2018</Year>                <Month>11</Month>                <Day>8</Day>                <Hour>6</Hour>                <Minute>1</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>epublish</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">30400234</ArticleId>            <ArticleId IdType="pii">cancers10110419</ArticleId>            <ArticleId IdType="doi">10.3390/cancers10110419</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle></PubmedArticleSet>